IGF::OT::IGF SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL

Irisys, Inc., San Diego CA

Investigators

Abstract

The contractor will produce about three hundred forty (340) vials of ISCOMATRIX according to the attached batch record under the cGMP condition for clinical use under a firm fixed type contract.